Blog
Biosimilar Surge Driving Need for Antibody Characterization
BlogAccurate protein characterization is particularly important in the biopharmaceutical industry, where product modifications can affect efficacy and safety. Here, we speak to Matthew Lauber, a consulting scientist who elaborates on the importance and challenges of biotherapeutic protein characterization, and discusses different techniques used for charge variant analysis.
Read More
Hybridoma vs Phage Display for Monoclonal Antibody Production
BlogThis blog highlights the key advantages and drawbacks of hybridoma development and phage display for a monoclonal antibody production in order to help you determine the best method for your needs.
Read More
Antibody Cascade Design Key to Customizing Success
BlogWe caught up with Abcam's Head of Custom Services, Jamie Campbell, who recently presented at the Protein & Antibody Engineering Summit, Europe. Jamie discusses the company’s approach to discovering antibodies – key reagents in drug discovery, in vitro diagnostics and therapeutics.
Read More
Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
BlogAssay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.
Read More
Combating Neurodegenerative and Age-related Diseases
BlogWe recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.
Read More
Immunotherapy Response Prediction in Urothelial Cancer
BlogWhile immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.
Read More
Developing Therapies to Fight Cancer and Autoimmune Diseases
BlogWe recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo MOA of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.
Read More
Developing Stem Cell Therapy Solutions for Liver Disease
BlogWe spoke with Eric Schuur, President and CEO of HepaTx, to learn how the company hopes to develop regenerative medicine solutions for people with liver disease. Eric provides an overview of the steps involved in hepatocyte production and provides insights on the hurdles that need to be overcome, to get these stem cells from the lab to the clinic.
Read More
Sustainability Through Innovation
BlogWith growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Read More
Making the Move to Continuous Bioprocessing
BlogBioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.
Read More
